Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Progression Free Survival × PE regimen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 4 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Solid Tumor Cancer 1 Progression Free Survival 1 Intracranial Germ Cell CNS Tumor, Childhood 1 Hormone Refractory Prostate Cancer 1 Carcinoma, Neuroendocrine 1 Carcinoma 1

Interventions

Etoposide 2 Cisplatin 2 osimertinib 1 apatinib 1 S 1 (combination) 1 PE regimen 1 Docetaxel 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03100955 2017-04-04

A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Qingdao University

Phase 3 Unknown

Progression Free Survival

Data powered by HemOnc (CC BY 4.0) Colophon ⚡